Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Change in Receivables (2021 - 2025)

Inmune Bio (INMB) has disclosed Change in Receivables for 5 consecutive years, with -$494000.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 786.11% to -$494000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29000.0 through Dec 2025, up 104.01% year-over-year, with the annual reading at $29000.0 for FY2025, 104.01% up from the prior year.
  • Change in Receivables hit -$494000.0 in Q4 2025 for Inmune Bio, down from $99000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $519000.0 in Q2 2025 to a low of -$6.0 million in Q4 2023.
  • Historically, Change in Receivables has averaged -$395000.0 across 5 years, with a median of -$20000.0 in 2022.
  • Biggest YoY gain for Change in Receivables was 420.0% in 2023; the steepest drop was 2522.58% in 2023.
  • Year by year, Change in Receivables stood at $403000.0 in 2021, then plummeted by 38.46% to $248000.0 in 2022, then plummeted by 2522.58% to -$6.0 million in 2023, then soared by 101.2% to $72000.0 in 2024, then crashed by 786.11% to -$494000.0 in 2025.
  • Business Quant data shows Change in Receivables for INMB at -$494000.0 in Q4 2025, $99000.0 in Q3 2025, and $519000.0 in Q2 2025.